References
- Armitage J. O., Dick F. R., Corder M P. Diffuse histiocytic lymphoma after bistologic conversion: a poor prognostic variant. Cancer Treatment Reports 1981; 65: 413–418
- Bastion Y., Sebban C., Berger F., et al. Incidence, predictive factors and outcome of lymphoma transformation in follicular lymphoma patients. Journal of Clinical Oncology 1997; 15: 1587–1594
- Rowbotham D., Wendon J., Williams R. Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut 1997; 42: 576–580
- Fergusson D. J., Allen L. W., Grien I. N.L. Surgical experience with staging laparotomy in 125 patients with lymphoma. Archives of Internal Medicine 1973; 131: 356–61
- Kim H., Dorfman R F. Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin's lymphoma. Cancer 1974; 33: 657–674
- Roth A., Kaloric K., Dominis M. Histologic and cytologic liver changes in 120 patients with malignant lymphomas. Tumori 1978; 64: 45–53
- Lotz M, Chabner J., De B., Vita V T. Patological staging of 100 consecutive untreated patients with non-Hodgkin's lymphomas: Extramedullary sites of disease. Cancer 1976; 37: 266–270
- Biemer J J. Hepatic manifestations of lymphomas. Annals of Clinical and Laboratory Science 1984; 14: 252–260
- Dich N. H., Goodman Z. D., Klein M A. Hepatic involvement in Hodgkin's disease: clues to the histologic diagnosis. Cancer 1989; 64: 2121–2126
- Zafrani E. J., Leclercq B., Vemant J. P., et al. Massive blastic infiltration of the liver: A cause of fulminant hepatic failure. Hepatology 1983; 3: 428–432
- Harrison H. B., Middleton H. M., Crosby J. H., et al. Fulminant hepatic failure: an unusual presentation of metastatic liver disease. Gastroenterology 1981; 80: 820–825
- Eras P., Scherlock P. Hepatic coma secondary secondary to metastatic liver disease. Annals of Internal Medicine 1971; 74: 581–583
- Sherlock S., Dooley J. The portal venous system and portal hypertension. Diseases of the liver and biliary system 10th edn, S. Sherlock, J. Dooley. Blackwell science, London 1997; 156
- Braude S., Portmann B., Gimson A. E.S., Williams R. Fulminant hepatic failure in non-Hodgkin's lymphoma. Postgraduate Medical Joumal 1982; 58: 301–304
- Desablens B., Garidi R., Tabuteau S., Fernandes J., Capiod J. C., Legrand S. May fludarabine favour occurrence of Richter's syndrome during B-CLL?. British Journal of Haematology 1998; 103: 192, Abs. p. 0764
- Pocock C., Matutes E., Wotherspoon A., Cunningham D., Catovsky D. Fludarabine therapy may precipitate large cell transformation in chronic lymphocytic leukemia but not in follicular lymphoma. Blood 1998; 92(Suppl 1)429a, Abs. 1774
- Salo J., Nomdedeu B., Bruguere M., et al. Acute liver failure due to non-Hodgkin's lymphoma. American Journal of Gastroenterology 1993; 88: 774–776
- Souto P., Romaozinho J. M., Figueiredo P., et al. Severe acute liver failure as the initial manifestation of haematological malignancy. European Journal of Gastroenterology and Hepatology 1997; 9: 1113–1115
- Yoshikawa M., Yamane Y., Yoneda S., et al. Acute hepatic failure due to hepatosplenic B-cell non-Hodgkin's lymphoma in a patient infected with hepatitis C virus. Journal of Gastroenterology 1998; 33: 880–885
- Shehab T. M., Kaminski M. S., Lok A. S.F. Acute liver failure due to hepatic involvement by lymphatic malignancy. Digestive Diseases and Sciences 1997; 42: 1400–1405
- Maryniak R. K., Konecki R. Two cases of Richter's syndrome. Acta Haematologica Polska 1991; 22: 165–169